Granting additional market exclusivity to the drug Ansaid

Name: Granting additional market exclusivity to the drug Ansaid
Author: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment.

by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment. · 1992

Cover of Granting additional market exclusivity to the drug Ansaid

No description available.

FlurbiprofenPatent extensionsPharmaceutical policyUpjohn Company

Granting additional market exclusivity to the drug Ansaid by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment. — book · Vinony